Sitagliptin Significantly Decreases the Ratio of Glycated Albumin to HbA1c in Patients with Type 2 Diabetes Mellitus

نویسندگان

  • Shogo Kurebayashi
  • Takashi Motomura
  • Kayoko Goya
  • Makoto Nakao
  • Kunihiko Hashimoto
  • Yasuhiko Morimoto
  • Tetsuhiro Kitamura
  • Iichiro Shimomura
  • Masafumi Koga
چکیده

Shogo Kurebayashi1, Takashi Motomura2, Kayoko Goya1, Makoto Nakao3, Kunihiko Hashimoto4, Yasuhiko Morimoto4, Tetsuhiro Kitamura5, AtsunoriFukuhara5, Bunzo Sato6, SojiKasayama6, Iichiro Shimomura5, Masafumi Koga7* and MichioOtsuki5 1Department of Internal Medicine, Nishinomiya Municipal Hospital, Japan 2MotomuraNaikaClinic, Fujiidera, Japan 3NakaoNaikaClinic, Ibaraki, Japan 4Department of Internal Medicine, Aizenbashi Hospital, Japan 5Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Japan 6Department of Medicine, Nissay Hospital, Japan 7Department of Internal Medicine, Kawanishi City Hospital, Japan

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Estimation of HbA1c response to sitagliptin by change in glycated albumin level for 2 weeks

UNLABELLED Aims/Introduction:  Since glycated albumin (GA) reflects shorter-term (about 2 weeks) control of plasma glucose levels compared with HbA1c, GA is thought to be a useful glycemic control indicator for the early period following commencement of the treatment of diabetes. In this study, we attempted to estimate HbA1c using the change in GA level before and after the first 2 weeks (ΔGA2w...

متن کامل

Add-on therapy with the DPP-4 inhibitor sitagliptin improves glycemic control in insulin-treated Japanese patients with type 2 diabetes mellitus.

The effect of add-on therapy with sitagliptin on glycemic control was prospectively investigated in patients with type 2 diabetes mellitus (T2DM) receiving insulin alone or insulin combined with oral antidiabetic drugs. Seventy-one patients were evaluated (38 men and 33 women aged 63.9 ± 10.2 years). They were divided into three groups, which were 45 patients receiving premixed insulin twice da...

متن کامل

Serum glycated albumin as a new glycemic marker in pediatric diabetes

PURPOSE Serum glycated albumin (GA) has been recently used as another glycemic marker that reflects shorter term glycemic control than glycated hemoglobin (HbA1c). Insulin secretory function and glycemic fluctuation might be correlated with the ratio of GA to HbA1c (GA/HbA1c) in diabetic adult patients. This study investigated the association of GA and GA/HbA1c ratio with the levels of fasting ...

متن کامل

Predictive factors of durability to sitagliptin: Slower reduction of glycated hemoglobin, older age and higher baseline glycated hemoglobin

AIMS/INTRODUCTION The goal of the present study was to evaluate predictive factors for good efficacy and durability to sitagliptin with ongoing metformin or metformin plus glimepiride therapy in a real practice situation. The present observational study was carried out over a 60-week period and involved Korean patients with type 2 diabetes mellitus. MATERIALS AND METHODS A total of 100 mg of ...

متن کامل

The durability of sitagliptin in elderly patients with type 2 diabetes

AIM To evaluate the durability of sitagliptin and to assess changes in clinical chronic complications following sitagliptin monotherapy for 48 months in elderly patients with type 2 diabetes mellitus (T2DM). SUBJECTS AND METHODS We enrolled 76 drug-naïve patients (40 women and 36 men; mean age: 71.3±11.7 years) with T2DM who received 25-100 mg of sitagliptin therapy from an outpatient clinic....

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2014